Related Experiment Videos
Beta-adrenergic antagonists in the treatment of glaucoma
1Glaucoma Research and Care Center, University of Parma, Italy. s.gandolfi@rsadvnet.it
European Journal of Ophthalmology
|October 11, 2001
Abstract
Purpose:
Beta-blockers have been used since the late 1970's as 'first-choice' in the treatment for glaucoma. Since the introduction of new molecules in clinical routine, the current role of beta-blockers in glaucoma therapy has been rediscussed. In particular, concerns have been raised regarding their actual safety profile.
Methods:
This review will focus on the latest advances on the efficacy and safety profiles of non-selective beta-blockers.
Conclusions:
The data provided will help to trace a more appropriate role for beta-blockers in glaucoma therapy.